News Articles Tagged: Pharmaceutical Recall

Understanding NDMA Impurities: A Pharmaceutical Industry Wake-Up Call

Discuss the implications of NDMA contamination in pharmaceuticals, using Ranitidine as a case study. Learn about detection, control, and the impact on drug safety standards, with insights from NINGBO INNO PHARMCHEM CO.,LTD.

A Consumer's Guide: Understanding Ranitidine Hydrochloride and Safety Alerts

This guide provides consumers with essential information on Ranitidine Hydrochloride, its historical uses, common side effects, and the critical safety alerts that led to its market withdrawal.

The NDMA Controversy: What You Need to Know About Ranitidine Hydrochloride's Past

Delve into the NDMA contamination issue that led to the recall of Ranitidine Hydrochloride. Understand the implications for pharmaceutical quality and consumer safety.

Navigating Valsartan Recalls and Ensuring API Purity: A Guide for Buyers

This article addresses the critical issue of valsartan recalls due to NDMA contamination and emphasizes the importance of sourcing pure valsartan API. NINGBO INNO PHARMCHEM CO.,LTD. highlights its commitment to quality control and reliable supply.

Valsartan Drug Recalls: Ensuring Safety and Quality in Pharmaceutical Sourcing

Examine the implications of Valsartan drug recalls due to impurities and how NINGBO INNO PHARMCHEM CO.,LTD. ensures the safety and quality of its Valsartan powder for manufacturers.